IXP-RAPID
LIVE

Serial Number

79180324

Owner

ImmuneXpress Pty Ltd

Attorney

Leigh Ann Lindquist

Filing Date

Sep 18, 2015

Add to watchlist:

No watchlists yet
View on USPTO

IXP-RAPID Trademark

Serial Number: 79180324 • Registration: 5262886

IXP-RAPID is a trademark filed by ImmuneXpress Pty Ltd on September 18, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ImmuneXpress Pty Ltd (6 trademarks)

425 Pontius Avenue. N., Suite 430
Seattle, WA 98109

Entity Type: 11

Trademark Details

Filing Date

September 18, 2015

Registration Date

August 15, 2017

Published for Opposition

May 30, 2017

Cancellation Date

September 18, 2025

Goods & Services

Pharmaceutical preparations and substances for treating systemic inflammation associated with infection; Clinical diagnostic reagents for medical or veterinary use, namely, medical diagnostic reagents not for laboratory use; biological and chemical test reagents for clinical and medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; Medical diagnostic testing apparatus for carrying out diagnostic tests particularly for the analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; diagnostic test apparatus in this class consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; Point of care medical devices, namely, devices for analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection

Medical services; Medical services in the field of pathology; Medical and pathology services being the analysis of body fluid samples, namely, medical testing for diagnostic or treatment purposes; medical services being molecular diagnostic services; Medical services, namely, taking of body fluid samples of others; information, advisory and consultancy services in relation to the aforementioned

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 9, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Apr 9, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 14, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 21, 2024 INTS
INVALIDATION PROCESSED
Nov 21, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 2, 2024 INTR
CANCELLED SECTION 71
Mar 1, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 15, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 5, 2017 FICS
FINAL DISPOSITION PROCESSED
Dec 5, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 15, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2017 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 28, 2017 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 23, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2017 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2017 PUBO
NOTIFICATION PROCESSED BY IB
May 27, 2017 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
May 18, 2017 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 10, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 10, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 21, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2017 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 28, 2017 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 10, 2017 PREV
ASSIGNED TO LIE
Mar 4, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2017 CNEA
NEW REPRESENTATIVE AT IB RECEIVED
Feb 10, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 2, 2016 GNFN
FINAL REFUSAL E-MAILED
Nov 2, 2016 GNFR
FINAL REFUSAL WRITTEN
Nov 2, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2016 CRFA
ASSIGNED TO LIE
Jul 23, 2016 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 20, 2016 PARI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2016 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2016 TROA
REFUSAL PROCESSED BY IB
Feb 5, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 19, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jan 19, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 15, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jan 14, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 13, 2016 MAFR
ASSIGNED TO EXAMINER
Jan 9, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 7, 2016 REPR